文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

美国、加拿大和英国基于症状的罗马 IV 功能性消化不良的成年人的流行病学、临床特征及相关因素:一项横断面基于人群的研究。

Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.

机构信息

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Center for Functional Gastrointestinal and Motility Disorders, University of North Carolina, Chapel Hill, NC, USA.

出版信息

Lancet Gastroenterol Hepatol. 2018 Apr;3(4):252-262. doi: 10.1016/S2468-1253(18)30003-7. Epub 2018 Feb 1.


DOI:10.1016/S2468-1253(18)30003-7
PMID:29396034
Abstract

BACKGROUND: The population prevalence, clinical characteristics, and associations for Rome IV functional dyspepsia are not known. Following the publication of the Rome IV criteria for functional gastrointestinal disorders, we aimed to assess the prevalence, characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults across the USA, Canada, and the UK. METHODS: We sent an internet-based cross-sectional health survey to adults in the general population of three English-speaking countries: the USA, Canada, and the UK. We used quota-based sampling to generate demographically balanced and population-representative samples. Individuals were invited to complete an online questionnaire on general health, without mention that the purpose of this survey was to examine gastrointestinal symptoms. We excluded participants who failed two attention-test questions or were excessively inconsistent on the three gastrointestinal questions that were presented twice in the survey for this particular purpose. The survey enquired about demographics, health-care visits, medications, somatisation, quality of life, and symptom-based criteria for Rome IV functional dyspepsia as well as for irritable bowel syndrome (IBS) and functional heartburn. We made subsequent comparisons between participants with Rome IV functional dyspepsia and controls without dyspepsia. The primary objective was to identify participants who fulfilled symptom-based criteria for Rome IV functional dyspepsia and categorise them into postprandial distress syndrome, epigastric pain syndrome, or overlapping subtypes. FINDINGS: 6300 general population adults completed the health survey; 2100 each from the USA, Canada, and the UK. 369 responses were deemed inconsistent, leaving data for 5931 adults. Rome IV functional dyspepsia was significantly more prevalent in the USA (232 [12%] of 1949) than in Canada (167 [8%] of 1988) and the UK (152 [8%] of 1994; p<0·0001). The subtype distribution was 61% postprandial distress syndrome, 18% epigastric pain syndrome, and 21% overlapping variant with both syndromes; this pattern was similar across the countries. Participants with functional dyspepsia had significantly greater health impairment and health-care usage than those without dyspepsia. Participants with the overlapping variant showed greater somatisation and poorer quality-of-life scores than did individuals with either postprandial distress syndrome or epigastric pain syndrome alone. In multivariate analysis, independent factors associated with all functional dyspepsia subtypes included worsening quality of life and the presence of symptoms compatible with functional heartburn and IBS, with functional heartburn and IBS having the strongest association with overlapping postprandial distress syndrome and epigastric pain syndrome. Notably, somatisation showed a positive association with postprandial distress syndrome and the overlapping variant, and use of antidepressants showed a negative association with postprandial distress syndrome. INTERPRETATION: Approximately 10% of the adult population fulfils symptom-based criteria for Rome IV functional dyspepsia and incurs considerable associated health impairment. The functional dyspepsia subtypes show differing associations, suggesting differences in pathophysiological processes or influences. FUNDING: The Rome Foundation, the US National Institute of Diabetes and Digestive and Kidney Diseases, the Swedish Medical Research Council, AFA Insurance, Ferring Pharmaceuticals, and the Faculty of Medicine, University of Gothenburg, Gothenburg, Sweden.

摘要

背景:罗马 IV 功能性消化不良的流行率、临床特征及其相关性尚不清楚。罗马 IV 功能性胃肠病标准公布后,我们旨在评估美国、加拿大和英国成年人中基于症状的罗马 IV 功能性消化不良的患病率、特征和相关性。

方法:我们向三个讲英语的国家(美国、加拿大和英国)的一般人群发送了一项基于互联网的横断面健康调查。我们采用配额抽样法生成人口统计学上均衡且具有代表性的样本。邀请个人完成一般健康状况的在线问卷调查,而不提及本次调查的目的是检查胃肠道症状。我们排除了未能通过两个注意力测试问题或在两次呈现用于此特定目的的三个胃肠道问题时表现出过度不一致的参与者。该调查询问了罗马 IV 功能性消化不良的人口统计学、医疗保健就诊情况、药物治疗、躯体化、生活质量以及基于症状的罗马 IV 功能性消化不良和肠易激综合征(IBS)和功能性烧心的标准。我们随后比较了罗马 IV 功能性消化不良患者和无消化不良患者之间的差异。主要目的是确定符合罗马 IV 功能性消化不良基于症状的标准的参与者,并将他们分为餐后不适综合征、上腹痛综合征或重叠亚型。

结果:共有 6300 名普通人群成年人完成了健康调查;美国、加拿大和英国各有 2100 人。369 份答卷被认为不一致,留下了 5931 名成年人的数据。罗马 IV 功能性消化不良在美国(1949 人中的 232 例[12%])明显比在加拿大(1988 人中的 167 例[8%])和英国(1994 人中的 152 例[8%])更为常见(p<0·0001)。亚型分布为 61%餐后不适综合征,18%上腹痛综合征,21%重叠变异型同时存在两种综合征;这种模式在各国之间相似。功能性消化不良患者的健康损害和医疗保健使用率明显高于无消化不良患者。重叠变异型患者的躯体化症状和生活质量评分较差,明显高于餐后不适综合征或上腹痛综合征患者。多变量分析显示,与所有功能性消化不良亚型相关的独立因素包括生活质量恶化,以及存在与功能性烧心和 IBS 相符的症状,功能性烧心和 IBS 与重叠型餐后不适综合征和上腹痛综合征的相关性最强。值得注意的是,躯体化与餐后不适综合征和重叠变异型呈正相关,而使用抗抑郁药与餐后不适综合征呈负相关。

结论:约 10%的成年人口符合罗马 IV 功能性消化不良的基于症状的标准,并伴有相当大的相关健康损害。功能性消化不良的亚型表现出不同的相关性,表明存在不同的病理生理过程或影响。

资金:罗马基金会、美国国立糖尿病、消化和肾脏疾病研究所、瑞典医学研究理事会、AFA 保险、费森尤斯制药公司以及瑞典哥德堡大学医学院,哥德堡,瑞典。

相似文献

[1]
Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.

Lancet Gastroenterol Hepatol. 2018-2-1

[2]
Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults.

Clin Gastroenterol Hepatol. 2018-5-29

[3]
Effects of the Rome IV Criteria to Functional Dyspepsia Symptoms in Saudi Arabia: Epidemiology and Clinical Practice.

Korean J Gastroenterol. 2020-12-25

[4]
The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.

Am J Gastroenterol. 2017-11-14

[5]
Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.

BMC Gastroenterol. 2018-3-17

[6]
Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.

Gastroenterology. 2020-1-7

[7]
The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.

BMC Gastroenterol. 2008-9-23

[8]
Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.

Am J Gastroenterol. 2010-9-7

[9]
Prevalence of Irritable Bowel Syndrome, Functional Dyspepsia and their Overlap in Bulgaria: a Population-Based Study.

J Gastrointestin Liver Dis. 2020-9-9

[10]
Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification.

Am J Gastroenterol. 2013-4-9

引用本文的文献

[1]
Dietary microbes and functional dyspepsia: modulating the gut microecology for therapeutic benefit.

Front Nutr. 2025-8-19

[2]
Efficacy and safety of the Shugan Jieyu capsule as a complementary treatment for functional dyspepsia: A systematic review and meta-analysis.

Medicine (Baltimore). 2025-8-29

[3]
Managing dyspepsia as a generalist.

Singapore Med J. 2025-7-1

[4]
Characterizing Duodenal Immune Microenvironment in Functional Dyspepsia: An AutoML-Driven Diagnostic Framework.

J Inflamm Res. 2025-7-15

[5]
Functional Dyspepsia and Its Subgroups: Prevalence and Impact in the Rome IV Global Epidemiology Study.

Aliment Pharmacol Ther. 2025-8

[6]
Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia.

Cochrane Database Syst Rev. 2025-5-8

[7]
Endoscopic Findings in Patients Presenting Dyspepsia: A Population-Based Study in Mashhad, North East of Iran.

Middle East J Dig Dis. 2025-1

[8]
Overlap of 'disorders of gut-brain interaction' and their impact on quality of life and somatization in a tertiary care center- A cross-sectional study.

Indian J Gastroenterol. 2025-4-15

[9]
The Duodenal Microenvironment in Functional Dyspepsia.

J Neurogastroenterol Motil. 2025-4-30

[10]
The efficacy and safety of auricular acupoint therapy on treating functional dyspepsia with insomnia: study protocol for a randomized controlled trial.

Front Med (Lausanne). 2025-3-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索